AZD1940 + Midazolam
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Low Back Pain
Conditions
Low Back Pain
Trial Timeline
Mar 1, 2008 → Nov 1, 2008
NCT ID
NCT00689780About AZD1940 + Midazolam
AZD1940 + Midazolam is a phase 1 stage product being developed by AstraZeneca for Low Back Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT00689780. Target conditions include Low Back Pain.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00689780 | Phase 1 | Completed |
Competing Products
20 competing products in Low Back Pain